In GBM, ASAH1 expression is associated with CD133+ GBM cells, a population of stem-like GBM cells which are highly invasive [8,16] and particularly sensitive to AKT inhibition leading to decreased growth and migration [17]. The gene discussed is PROM1; the disease is glioblastoma.